Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Aging (Jul 2022)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • Gut-Brain Axis (Jul 2021)
    • Tumor Microenvironment (Mar 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Osteoclasts are essential for TNF-α–mediated joint destruction
Kurt Redlich, … , Erwin F. Wagner, Georg Schett
Kurt Redlich, … , Erwin F. Wagner, Georg Schett
Published November 15, 2002
Citation Information: J Clin Invest. 2002;110(10):1419-1427. https://doi.org/10.1172/JCI15582.
View: Text | PDF
Article Immunology

Osteoclasts are essential for TNF-α–mediated joint destruction

  • Text
  • PDF
Abstract

Research Article

Authors

Kurt Redlich, Silvia Hayer, Romeo Ricci, Jean-Pierre David, Makiyeh Tohidast-Akrad, George Kollias, Günter Steiner, Josef S. Smolen, Erwin F. Wagner, Georg Schett

×

Figure 1

Options: View larger image (or click on image) Download as PowerPoint
There are no differences in the clinical course of arthritis between hTN...
There are no differences in the clinical course of arthritis between hTNFtg and c-fos–/–hTNFtg mice. Clinical course of arthritis indicated by (a) joint swelling and (b) grip strength was assessed in wild-type mice (filled triangles), c-fos–/– mice (open circles), hTNFtg mice (open diamonds), and c-fos–/–hTNFtg mice (filled squares). Asterisks indicate a significant (P < 0.01) increase in joint swelling and decrease in grip strength in hTNFtg and c-fos–/–hTNFtg mice compared with baseline and with wild-type and c-fos–/– mice.

Copyright © 2022 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts